Comparison of final infarct volumes in patients who received endovascular therapy or intravenous thrombolysis for acute intracranial large-vessel occlusions

JAMA Neurology

Volumn 70, Issue 7, 2013, Pages 831-836

  Rangaraju, Srikant ^a   Owada, Kumiko ^a   Noorian, Ali Reza ^a   Nogueira, Raul G ^a   Nahab, Fadi ^a   Glenn, Brenda A ^a   Belagaje, Samir R ^a   Anderson, Aaron M ^a   Frankel, Michael R ^a   Gupta, Rishi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE INTRACRANIAL LARGE VESSEL OCCLUSION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN CIRCULATION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; REPERFUSION; RETROSPECTIVE STUDY;

EID: 84880312581     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.413     Document Type: Article

References (16)

1. SmithWS, Lev MH, English JD, et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke. 2009;40(12): 3834-3840.
2. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41(10):2254-2258.
3. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, SmithWS; MERCI; Multi MERCIWriting Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke. 2009;40(12):3777-3783.
4. Yoo AJ, Chaudhry ZA, Nogueira RG, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke. 2012;43(5):1323-1330.
5. Barber PA, Demchuk AM, Zhang J, Buchan AM; ASPECTS Study Group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000;355(9216): 1670-1674.
6. Zaidat OO, LazzaroMA, Liebeskind DS, et al. Revascularization grading in endovascular acute ischemic stroke therapy. Neurology. 2012;79(13)(suppl 1):S110-S116.
7. Vora NA, Shook SJ, Schumacher HC, et al. A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: validation from results of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke. 2011;42(3):645-649.
8. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: ameta-analysis. Stroke. 2007;38(3):967-973.
9. Nogueira RG, Lutsep HL, Gupta R, et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380(9849): 1231-1240.
10. Saver JL, Jahan R, Levy EI, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849): 1241-1249.
11. ClarkW, Lutsep S, Barnwell H, et al; Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40(8):2761-2768.
12. Fields JD, Lutsep HL, SmithWS; MERCI Multi MERCI Investigators. Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and Multi MERCI trials. AJNR Am J Neuroradiol. 2011;32(11):2170-2174.
13. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42(6):1775-1777.
14. Leker RR, Molina C, Cockroft K, et al. Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients. Cerebrovasc Dis. 2012;34(4):263-271.
15. Bluhmki E, Chamorro A, Dávalos A, et al. Stroke treatment with alteplase given 3. 0-4. 5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8(12): 1095-1102.
16. Rai AT, Carpenter JS, Raghuram K, Roberts TD, Rodgers D, Hobbs GR. Endovascular therapy yields significantly superior outcomes for large vessel occlusions compared with intravenous thrombolysis: is it time to randomize [published online July 28, 2012]? J Neurointerv Surg. doi:10. 1136/neurintsurg-2012-010429.